ID: ALA4784996

Max Phase: Preclinical

Molecular Formula: C16H14O4

Molecular Weight: 270.28

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(O)cc1/C=C/C(=O)c1ccc(O)cc1

Standard InChI:  InChI=1S/C16H14O4/c1-20-16-9-7-14(18)10-12(16)4-8-15(19)11-2-5-13(17)6-3-11/h2-10,17-18H,1H3/b8-4+

Standard InChI Key:  GQGAQNAZFBHQAB-XBXARRHUSA-N

Associated Targets(Human)

Calpain 1 1269 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.28Molecular Weight (Monoisotopic): 270.0892AlogP: 3.00#Rotatable Bonds: 4
Polar Surface Area: 66.76Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.87CX Basic pKa: CX LogP: 3.13CX LogD: 3.00
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.66Np Likeness Score: 0.33

References

1. Jeon KH,Lee E,Jun KY,Eom JE,Kwak SY,Na Y,Kwon Y.  (2016)  Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against μ-calpain and cathepsin B through the downregulation of tau phosphorylation and insoluble Aβ peptide formation.,  121  [PMID:27318120] [10.1016/j.ejmech.2016.06.008]

Source